Compare Visa Inc (V) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Visa Inc vs Zoetis Inc — how do they compare? Visa Inc trades at $369.75 (market cap $693.57B), while Zoetis Inc trades at $73.65 (market cap $30.40B). The key difference: Visa Inc is far larger — about 22.8× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.88%). Which is the better fit depends on your goals.
| V | ZTS | |
|---|---|---|
Market Cap | $693.57B | $30.40B |
Volume | 10,431,336 | — |
Sector | Financials | Health |
52-Week High | $384.14 | $150.61 |
52-Week Low | $295.52 | $71.91 |
Enterprise Value | $704.15B | $37.96B |
Dividend Yield | 0.73% | 2.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Visa (V) trades at $368.64, down 1.71% on the day, but maintains strong fundamentals with a 50.78% net income margin and consistent earnings beats. The stock is supported by a bullish technical signal, with key support at $366 and resistance at $372. Recent developments include the launch of Intelligent Commerce Connect to facilitate AI-driven commerce, positioning the company for future growth amid digital payment expansion.
The outlook for Visa remains positive, driven by robust profitability, strategic AI initiatives, and a consensus price target of $430.93 implying 17% upside. Risks include competitive pressures from fintech and stablecoins, as well as regulatory scrutiny. Wall Street sentiment is overwhelmingly bullish with 85% of analysts rating it a Buy, supported by institutional accumulation.
Zoetis (ZTS) trades at $73.60, down 2.92% amid bearish technical signals and mixed earnings. The stock faces pressure from weakening U.S. companion animal sales and competitive headwinds, though profitability remains strong with 71.67% gross margins and 27.69% net income margin. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a guidance cut. Analyst consensus is divided with 45% Buy ratings and a $93.40 price target, suggesting 27% upside from current levels.
The outlook balances valuation appeal (P/E of 12) against near-term operational challenges. Investment opportunity lies in market dominance and robust cash flow generation, while risks include sustained pet health demand softness and competitive pricing pressure. The stock trades near support at $73, with institutional sentiment mixed amid recent portfolio adjustments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
